Experience

Lassogen, Inc.
• United States
• Biotechnology Research
• 1 - 100 Employee
• Founder, President and CEO

  • May 2019 - Present


Snap Bio, Inc.

• United States
• Biotechnology Research

• Founder, President and CEO

  • May 2017 - Nov 2019

  Developing new highly selective kinase inhibitors derived from potent natural scaffolds to improve survival in patients with cancer. Developing new highly selective kinase inhibitors derived from potent natural scaffolds to improve survival in patients with cancer.



Genomatica

• Information Technology & Services

• Executive VP and CTO

  • 2006 - 2017

  Developed a systems-based platform for rational engineering of biosynthesis pathways and organisms to produce small molecules. Developed a systems-based platform for rational engineering of biosynthesis pathways and organisms to produce small molecules.



Diversa Corporation

• Biotechnology Research
• 1 - 100 Employee

• Senior Vice President, Head of R&D

  • 2000 - 2006

  Advanced novel biotech platform for discovering and evolving novel enzymes and small molecules for developing novel therapeutics, nutrition, and food applications. Advanced novel biotech platform for discovering and evolving novel enzymes and small molecules for developing novel therapeutics, nutrition, and food applications.



Chiroscience Pharmaceuticals

• Director

  • 1996 - 2000

  Developed technologies for drug discovery and development. Developed technologies for drug discovery and development.



Duke University, Department of Chemistry and Biochemistry

• Professor

  • 1992 - 1996

  Developed technology for discovering and developing new drugs, including the DuPHOS systems for asymmetric synthesis of unnatural amino acids, peptides, and other small molecules. Developed technology for discovering and developing new drugs, including the DuPHOS systems for asymmetric synthesis of unnatural amino acids, peptides, and other small molecules.



Massachusetts Institute of Technology

• United States
• Higher Education
• 700 & Above Employee

• Post-doctoral Associate

  • 1986 - 1988

  Worked with Barry Sharpless on new synthesis methods, including asymmetric dihydroxylation technology. Worked with Barry Sharpless on new synthesis methods, including asymmetric dihydroxylation technology.